Evidence map›Paper›PMID 22105160›Full record

ArticleJournal of natural medicines2012

Preventive effect of Terminalia bellirica on obesity and metabolic disorders in spontaneously obese type 2 diabetic model mice.

Hiroko Makihara, Tsutomu Shimada, Eriko Machida, Masatomi Oota, Rika Nagamine, Masahito Tsubata, Kaoru Kinoshita, Kunio Takahashi, Masaki Aburada

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Plants of the GenusFrontiers in pharmacology · 2020
    Review
  7. Review
  8. Oxidative medicine and cellular longevity · 2018
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hiroko MakiharaGraduate School of Pharmaceutical Sciences, Graduate School of Musashino University, 1-1-20 Shinmachi, Nishitokyo, Tokyo 202-8585, Japan. hiro_ma@musashino-u.ac.jp
Tsutomu Shimada
Eriko Machida
Masatomi Oota
Rika Nagamine
Masahito Tsubata
Kaoru Kinoshita
Kunio Takahashi
Masaki Aburada
Musashino University · JPMeiji Pharmaceutical University · JPNippon Shinyaku (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral obesity induces insulin resistance and is recognized as an important risk factor for metabolic syndrome (MS). Therefore, inhibition of lipid absorption from the intestine is regarded as an effective way of preventing MS. Terminalia bellirica is extensively used in Ayurvedic medicine in India and neighboring countries, and the fruit of this plant has been reported to have hypoglycemic and hypolipidemic effects. In this study, we investigated the preventive effect of a hot water extract of T. bellirica fruit (TB) on obesity and various metabolic disorders, and explored its molecular mechanisms and active ingredients. TB treatment had a preventive effect on obesity, insulin resistance, and hyperlipidemia in spontaneously obese type 2 diabetic TSOD mice. To clarify the molecular mechanisms of TB in preventing obesity, we investigated the inhibitory effect on lipid absorption. TB suppressed absorption of triacylglycerol in an olive oil loading test (in vivo) and showed a strong inhibitory effect on pancreatic lipase activity (in vitro). Furthermore, a search for the active ingredients in TB revealed that gallic acid is the component primarily responsible for the inhibition of pancreatic lipase activity. Thus, our findings indicate that TB could be useful in preventing MS. The mechanisms probably involve suppression of the absorption of meal-derived lipids mediated by gallic acid.

Indexed as

AnimalsAnti-Obesity AgentsDiabetes Mellitus, Type 2HyperlipidemiasInsulin ResistanceMaleMiceObesityPlant ExtractsTerminaliaAnti-Obesity AgentsPlant Extracts

Identifiers

PMID22105160
OpenAlexW2094834440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.